Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
RANI: Rani Therapeutics Holdings, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
RANI
The Story
RANI
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
-1093.0%
ROIC
-87.7%
Financially safe
Stretched
Debt / equity
0.14×
Interest coverage
-17.0×
Current ratio
3.40×
Rani Therapeutics Holdings, Inc.
RANI
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Rani Therapeutics Holdings, Inc.
RANI
NASDAQ
·
USD
·
Closed
$0.77
−5.63%
$0.77
−$0.05 (5.63%)
52W Range
10th
pctl
Volume
0.44×
avg
Mkt Cap
50.56M
USD
P/E
-1.9
TTM
Div Yield
–
ann
52W Range
10th
pctl
Volume
0.44×
avg
Market Cap
50.56M
USD
P/E Ratio
-1.9
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings